Planet Biotechnology
Planet Biotechnology Inc., based in Hayward, CA, is a pioneering company that produced the first plant-made antibody, or plantibody, tested in a clinical trial. With a focus on discovering, developing, and commercializing antibody-based therapeutic and preventative products, the company aims to address significant underserved medical needs through the cultivation of genetically modified green plants.
Among its notable products are CMG2-Fc, an immunoadhesin for the treatment and prevention of inhalational anthrax, and DPP4-Fc, designed to treat MERS coronavirus infection. Additionally, Planet Biotechnology offers contract protein expression and purification services, collaborating on projects that support protein expression in tobacco plants.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.